Cancer Research The Future of Cancer Research: Science and Patient Impact  Translational Medicine Conference in Israel
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 49, 6738-6744, December 1, 1989]
© 1989 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Taniguchi, S.
Right arrow Articles by Baba, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Taniguchi, S.
Right arrow Articles by Baba, T.

High Invasiveness Associated with Augmentation of Motility in a fos-transferred Highly Metastatic Rat 3Y1 Cell Line1

Shun'ichiro Taniguchi2, Masaaki Tatsuka3, Kohji Nakamatsu, Mitsuse Inoue, Hiroyuki Sadano, Hiroshi Okazaki, Hideyuki Iwamoto and Tsuneo Baba

Department of Experimental Cell Research, Medical Institute of Bioregulation [S. T., K. N., M. I., H. S., T. B.], and Division of Orthopedic Surgery, Faculty of Medicine [H. I.], Kyushu University, Maidashi 3-1-1, Higashi-ku, Fukuoka 812; Department of Oncogene Research, Research Institute for Microbial Diseases, Osaka University, Suita 565 [M. T.]; and New Hoechst Building, No. 10-16, 8-chome, Akasaka, Minami-ku, Tokyo [H. O.], Japan

We previously reported that v-fos transfer to a src-transformed rat 3Y1 cell line enhanced lung metastasis. To clarify the mechanism of this enhancement, we compared various biological factors related to metastatic potential between a fos-transferred highly metastatic cell line (fos-SR-3Y1-202) and the control cell line transferred with genetic marker (pSV2-neo) plus pBR322, neo-SR-3Y1-200. Lung arrest, the effect of lung extract on cell growth, or sensitivity to natural killer cells could not explain the higher metastasis of fos-SR-3Y1-202, compared to findings with neo-SR-3Y1-200. The invasiveness, assessed by penetration through a Matrigel-coated filter was about 5 times higher in fos-SR-3Y1-202 than in neo-SR-3Y1-200; high invasiveness in vitro was also observed in a fos-transferred mixed-population cell line (fos-SR-3Y1-200) and fos-transferred highly metastatic clones. Histopathological evidence of an in vivo tumor also showed the high invasiveness of fos-SR-3Y1-202 cells. To elucidate the causes of the increased invasiveness of fos-SR-3Y1-202, attachment of the cells to Matrigel and its components, such as laminin and type IV collagen, type IV collagenase activity, and motility were examined. Attachment of the cells to the substrate coated on Petri dishes or the activity of type IV collagenase did not differ significantly. On the other hand, cell motility, determined by a new method to directly quantitate alteration of cell shape continuously, using video image analysis and computor techniques, was higher in fos-SR-3Y1-202 than in neo-SR-3Y1-200. Thus, the fos-transferred cell line, fos-SR-3Y1-202 has a high invasiveness, in association with augmentation of motility, hence the enhancement in metastatic potential.

1 Supported in part by a Grant-in-Aid for Cancer Research from the Ministry of Education, Science and Culture and from the Ministry of Health and Welfare, Japan.

2 To whom requests for reprints should be addressed.

3 Present address: Department of Molecular Bioregulation, Institute of Molecular and Cellular Biology for Pharmaceutical Sciences, Kyoto Pharmaceutical University, Yamashina, Kyoto 607, Japan.

Received 3/20/89. Revised 8/28/89. Accepted 9/ 1/89.




This article has been cited by other articles:


Home page
Endocr Relat CancerHome page
T. Suzuki, A. Inoue, Y. Miki, T. Moriya, J.-i. Akahira, T. Ishida, H. Hirakawa, Y. Yamaguchi, S.-i. Hayashi, and H. Sasano
Early growth responsive gene 3 in human breast carcinoma: a regulator of estrogen-meditated invasion and a potent prognostic factor
Endocr. Relat. Cancer, June 1, 2007; 14(2): 279 - 292.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Chen, M. Cho, K. Karlsberg, D. Zhou, and Y.-C. Yuan
Biochemical and Biological Characterization of a Novel Anti-aromatase Coumarin Derivative
J. Biol. Chem., November 12, 2004; 279(46): 48071 - 48078.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
N. Itano, T. Sawai, F. Atsumi, O. Miyaishi, S. Taniguchi, R. Kannagi, M. Hamaguchi, and K. Kimata
Selective Expression and Functional Characteristics of Three Mammalian Hyaluronan Synthases in Oncogenic Malignant Transformation
J. Biol. Chem., April 30, 2004; 279(18): 18679 - 18687.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
B. Anand-Apte and B. Zetter
Signaling Mechanisms in Growth Factor-Stimulated Cell Motility
Stem Cells, July 1, 1997; 15(4): 259 - 267.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1989 by the American Association for Cancer Research.